Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Cid

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Autoimmunity Reviews|January 7, 2022
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literatureClara Pouchelon, Marcella Visentini, Giacomo Emmi, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Leukemia|March 18, 2021
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphomaJuan Garcia Valero, Alba Matas-Céspedes, Fabián Arenas, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Annals of the Rheumatic Diseases|December 25, 2015
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritisMarc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, et al.
Kidney International Reports|April 11, 2018
The European Vasculitis Society 2016 Meeting ReportIngeborg M Bajema, Jan A Bruijn, Alina Casian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumorsLudmila Matyakhina, Thalia A Bei, Sarah R McWhinney, et al.
Rheumatology (Oxford, England)|December 23, 2022
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre studyManuel Alfredo Podestà, Federica Mescia, Anna Ricchiuto, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Autoimmunity Reviews|January 7, 2022
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literatureClara Pouchelon, Marcella Visentini, Giacomo Emmi, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Leukemia|March 18, 2021
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphomaJuan Garcia Valero, Alba Matas-Céspedes, Fabián Arenas, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Annals of the Rheumatic Diseases|December 25, 2015
Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritisMarc Corbera-Bellalta, Ester Planas-Rigol, Ester Lozano, et al.
Kidney International Reports|April 11, 2018
The European Vasculitis Society 2016 Meeting ReportIngeborg M Bajema, Jan A Bruijn, Alina Casian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitisMartin Fuchs, Matthias Briel, Thomas Daikeler, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumorsLudmila Matyakhina, Thalia A Bei, Sarah R McWhinney, et al.
Rheumatology (Oxford, England)|December 23, 2022
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre studyManuel Alfredo Podestà, Federica Mescia, Anna Ricchiuto, et al.
Pageof 15